238 related articles for article (PubMed ID: 21680758)
1. Long-term outcome of Spitz-type melanocytic tumors.
Sepehr A; Chao E; Trefrey B; Blackford A; Duncan LM; Flotte TJ; Sober A; Mihm MC; Tsao H
Arch Dermatol; 2011 Oct; 147(10):1173-9. PubMed ID: 21680758
[TBL] [Abstract][Full Text] [Related]
2. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.
Ludgate MW; Fullen DR; Lee J; Lowe L; Bradford C; Geiger J; Schwartz J; Johnson TM
Cancer; 2009 Feb; 115(3):631-41. PubMed ID: 19123453
[TBL] [Abstract][Full Text] [Related]
3. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
4. Spitz nevus and atypical spitzoid neoplasm.
Miteva M; Lazova R
Semin Cutan Med Surg; 2010 Sep; 29(3):165-73. PubMed ID: 21051010
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Demographic Study of Atypical Spitz Nevi and Malignant Melanoma.
Dika E; Lambertini M; Venturi F; Veronesi G; Mastroeni S; Hrvatin Stancic B; Bergant-Suhodolcan A
Acta Dermatovenerol Croat; 2023 Dec; 31(3):165-168. PubMed ID: 38439731
[TBL] [Abstract][Full Text] [Related]
6. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).
Murali R; Sharma RN; Thompson JF; Stretch JR; Lee CS; McCarthy SW; Scolyer RA
Ann Surg Oncol; 2008 Jan; 15(1):302-9. PubMed ID: 18000712
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.
Lott JP; Wititsuwannakul J; Lee JJ; Ariyan S; Narayan D; Kluger HH; Lazova R
J Am Acad Dermatol; 2014 Dec; 71(6):1077-82. PubMed ID: 25308882
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions.
Saraggi D; Salmaso R; Zamuner C; Munari G; Lanza C; Alaibac MS; Bassetto F; Rugge M; Montesco MC; Cerroni L; Fassan M
J Am Acad Dermatol; 2018 Oct; 79(4):728-735. PubMed ID: 29920315
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcomes of spitzoid proliferations in children and adolescents.
Bartenstein DW; Fisher JM; Stamoulis C; Weldon C; Huang JT; Gellis SE; Liang MG; Schmidt B; Hawryluk EB
Br J Dermatol; 2019 Aug; 181(2):366-372. PubMed ID: 30467833
[TBL] [Abstract][Full Text] [Related]
11. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
12. Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors.
Hung T; Piris A; Lobo A; Mihm MC; Sober AJ; Tsao H; Tanabe KK; Duncan LM
Hum Pathol; 2013 Jan; 44(1):87-94. PubMed ID: 22939951
[TBL] [Abstract][Full Text] [Related]
14. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
[TBL] [Abstract][Full Text] [Related]
15. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
16. PRAME immunohistochemistry of spitzoid neoplasms.
Koh SS; Lau SK; Scapa JV; Cassarino DS
J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
18. Spitz melanoma is a distinct subset of spitzoid melanoma.
Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic nevi with Spitz differentiation: diagnosis and management.
Ahmadi N; Davison SP; Kauffman CL
Laryngoscope; 2010 Dec; 120(12):2385-90. PubMed ID: 21072755
[TBL] [Abstract][Full Text] [Related]
20. Spitz Nevi and Other Spitzoid Neoplasms in Children: Overview of Incidence Data and Diagnostic Criteria.
Dika E; Ravaioli GM; Fanti PA; Neri I; Patrizi A
Pediatr Dermatol; 2017 Jan; 34(1):25-32. PubMed ID: 27874206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]